Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Peter S. N. van Rossum"'
Autor:
David A. Palma, Meredith E. Giuliani, Rohann J. M. Correa, Famke L. Schneiders, Stephen Harrow, Matthias Guckenberger, Tina Zhang, Houda Bahig, Sashendra Senthi, Peter Chung, Robert Olson, Michael Lock, Srinivas Raman, Glenn S. Bauman, Benjamin H. Lok, Joanna M. Laba, Rachel M. Glicksman, Timothy K. Nguyen, Pencilla Lang, Joelle Helou, Christopher D. Goodman, Lucas C. Mendez, Peter S. N. van Rossum, Andrew Warner, Stewart Gaede, Alison L. Allan
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-15 (2024)
Abstract Background Emerging randomized data, mostly from phase II trials, have suggested that patients with oligometastatic cancers may benefit from ablative treatments such as stereotactic ablative radiotherapy (SABR). However, phase III data testi
Externí odkaz:
https://doaj.org/article/2b8baa340960407cab86422d2a88489d
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/0fbff3d6bf644f1ea565371be2b26db1
Autor:
Peter S. N. van Rossum, Celia Juan-Cruz, Barbara Stam, Maddalena M. G. Rossi, Steven H. Lin, Azadeh Abravan, José S. A. Belderbos, Jan-Jakob Sonke
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundSevere radiation-induced lymphopenia (RIL) in patients undergoing chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC) is associated with decreased immunotherapy efficacy and survival. At The Christie and MD Anderson Cancer Center
Externí odkaz:
https://doaj.org/article/2e6c1dc3c51e45f19a7dd9efbf06b813
Autor:
Arnas Rakauskas, Max Peters, Paul Martel, Peter S. N. van Rossum, Stefano La Rosa, Jean-Yves Meuwly, Beat Roth, Massimo Valerio
Publikováno v:
PLoS ONE, Vol 18, Iss 1 (2023)
Introduction High-resolution micro-ultrasound (micro-US) is a novel precise imaging modality that allows targeted prostate biopsies and multiparametric magnet resonance imaging (mpMRI) fusion. Its high resolution relying on a 29 MHz transducer allows
Externí odkaz:
https://doaj.org/article/00440cd0aa1041738bf59ed6983b439c
Autor:
Mathijs L. Tomassen, Pim J. J. Damen, Helena M. Verkooijen, Max Peters, Janneke van der Stap, Anne S. R. van Lindert, Joost J. C. Verhoeff, Peter S. N. van Rossum
Publikováno v:
Acta Oncologica. 62:237-244
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5df8c4c59cfab8c5413baa5e599cf16a
https://doi.org/10.1080/0284186x.2023.2183778
https://doi.org/10.1080/0284186x.2023.2183778
Autor:
Tiuri E. Kroese, George S. Buijs, Matthijs D. L. Burger, Jelle P. Ruurda, Stella Mook, Lodewijk A. A. Brosens, Peter S. N. van Rossum, Richard van Hillegersberg
Publikováno v:
Annals of Surgical Oncology. 29:4848-4857
Background The primary goal of this study was to determine overall survival (OS) in patients who underwent local treatment (metastasectomy or stereotactic body radiotherapy [SBRT]) or systemic therapy (chemotherapy or targeted therapy) for oligometas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30bc838e75809a3dfbd9e9cc6e559f05
https://doi.org/10.1245/s10434-022-11541-0
https://doi.org/10.1245/s10434-022-11541-0
Publikováno v:
Annals of Surgical Oncology. 29:4858-4860
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea768911d86ec7b3d91a248975a5a2d
https://doi.org/10.1245/s10434-022-11546-9
https://doi.org/10.1245/s10434-022-11546-9
Autor:
Tiuri E. Kroese, George S. Buijs, Matthijs D. L. Burger, Jelle P. Ruurda, Stella Mook, Lodewijk A. A. Brosens, Peter S. N. van Rossum, Richard van Hillegersberg
Publikováno v:
Annals of Surgical Oncology. 29:4861-4862
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0ef09b75ccff25af158ab7871458909
https://doi.org/10.1245/s10434-022-11614-0
https://doi.org/10.1245/s10434-022-11614-0
Autor:
W Hugo, van Joolingen, Marnix J A, Rasing, Max, Peters, Anne S R, van Lindert, Linda M, de Heer, Mieke J, Aarts, Joost J C, Verhoeff, Peter S N, van Rossum
Publikováno v:
Annals of surgical oncology. 29(3)
Irradical resection of non-small-cell lung cancer (NSCLC) is a detrimental prognostic factor. Recently, Rasing et al. presented an internationally validated risk score for pre-treatment prediction of irradical resection. We hypothesized that chemorad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df02980124bba44d6001cb6e864680d6
https://pubmed.ncbi.nlm.nih.gov/34718916
https://pubmed.ncbi.nlm.nih.gov/34718916
Autor:
Tiuri E, Kroese, George S, Buijs, Matthijs D L, Burger, Jelle P, Ruurda, Stella, Mook, Lodewijk A A, Brosens, Peter S N, van Rossum, Richard, van Hillegersberg
Publikováno v:
Annals of surgical oncology. 29(8)
The primary goal of this study was to determine overall survival (OS) in patients who underwent local treatment (metastasectomy or stereotactic body radiotherapy [SBRT]) or systemic therapy (chemotherapy or targeted therapy) for oligometastatic esoph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c6f19600ac20983cae58e9ec21c44999
https://pubmed.ncbi.nlm.nih.gov/35381938
https://pubmed.ncbi.nlm.nih.gov/35381938